Topics

Chelsea Therapeutics Company Profile

17:26 EST 21st January 2020 | BioPortfolio

We are a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of a variety of human diseases. Our strategy is to develop technologies that address important unmet medical needs or offer improved, cost-effective alternatives to current methods of treatment. Specifically, Chelsea concentrates its efforts on acquiring and developing technologies for the treatment of rheumatoid arthritis (RA), psoriasis, cancer and other immunological disorders.

Location

13950 Ballantyne Corporate Place
Suite 325
Charlotte
North Carolina
28277
United States of America

Contact

Phone: 704 341 1516
Fax: 704 752 1479
Email: webemail1@chelsearx.com


News Articles [806 Associated News Articles listed on BioPortfolio]

Frank Lampard provides update on injuries and contract negotiations | Official Site – Chelsea FC

Frank Lampard provides update on injuries and contract negotiations | Official Site Chelsea FCReading 3-4 Chelsea: Mason Mount scores twice in exciting friendly BBC SportThis technically gifted...

11pm Chelsea transfer news LIVE: Pereira shortlisted for Blues job, Lampard talks LATEST, Benitez available – The Sun

11pm Chelsea transfer news LIVE: Pereira shortlisted for Blues job, Lampard talks LATEST, Benitez available The SunFrank Lampard: Chelsea given permission to hold talks with Derby manager BBC SportC...

1am Chelsea transfer news LIVE: Hudson-Odoi wanted at Sarri’s Juventus but not Higuain, away kit LEAKED – The Sun

1am Chelsea transfer news LIVE: Hudson-Odoi wanted at Sarri's Juventus but not Higuain, away kit LEAKED The SunChelsea delay announcing Frank Lampard's return to Stamford Bridge as new manager Mirro...

N’Golo Kante marks Virgil van Dijk at a corner in Chelsea vs Liverpool Super Cup game – talkSPORT.com

N'Golo Kante marks Virgil van Dijk at a corner in Chelsea vs Liverpool Super Cup game talkSPORT.comSuper Cup was fun but it also shows why 39th game remains a bad idea The TimesJürgen Klopp praises...

Premier League team news: How Man Utd, Arsenal, Liverpool, Tottenham, Chelsea and City will line-up – The Independent

Premier League team news: How Man Utd, Arsenal, Liverpool, Tottenham, Chelsea and City will line-up The IndependentPep Guardiola, Frank Lampard plus more - Friday's Premier League news conferences - ...

Report: Agnelli meets Sarri – Football Italia

Report: Agnelli meets Sarri Football ItaliaVideo footage emerges of David Luiz appearing to ELBOW Gonzalo Higuain Daily MailChelsea vs Arsenal: 'I could play against their midfield' - Graeme Souness...

Transfer news LIVE: De Ligt to Man Utd, Chelsea Coutinho ‘discussions’, Liverpool, Arsenal – Express

Transfer news LIVE: De Ligt to Man Utd, Chelsea Coutinho 'discussions', Liverpool, Arsenal ExpressPremier League fixtures 2019-20: Season starts with Liverpool hosting Norwich BBC SportEnglish press...

Chelsea could move to re-sign Nathan Ake if Frank Lampard wants David Luiz replacement after transfer ban – The Telegraph

Chelsea could move to re-sign Nathan Ake if Frank Lampard wants David Luiz replacement after transfer ban The TelegraphLukaku: Inter Milan sign Belgium striker from Manchester United for £74m B...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [418 Associated PubMed Articles listed on BioPortfolio]

Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after Stroke.

Digital therapeutics is an evidence-based intervention using high-quality software, with the sole purpose of treatment. As many healthcare systems are encountering high demands of quality outcomes, th...

Measurement of mRNA therapeutics: method development and validation challenges.

The progression of chemically modified mRNA therapeutics through development pipelines is accelerating for many disease indications and the need to assess these analytes is becoming more routine for t...

Dr E. Keith Borden: Inaugural President of the Canadian Association for Population Therapeutics.

Pharmacovigilance 2030: Invited Commentary for the January 2020 "Futures" Edition of Clinical Pharmacology and Therapeutics.

Metabolism: A Burning Opioid Issue in Obesity Therapeutics.

Food restriction triggers a lowering in body temperature. A new study now provides a mechanism for this process that relies on opioid signaling in the hypothalamus. These observations suggest potentia...

Clinical Trials [211 Associated Clinical Trials listed on BioPortfolio]

Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations

The goal of this study is to implement and in a controlled randomised trial test a program to identify and overcome barriers to CRC screening and thus improve CRC screening rates at MGH Ch...

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1417 Associated Companies listed on BioPortfolio]

Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires, develops and commercializes innovative products for the treatment of a variety of huma...

Chelsea Therapeutics

We are a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of a variety of human diseases. Our strategy is to develop technologies that addr...

Chelsea Hutchison Foundation

Chelsea Green Publishing Company

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Chelsea Therapeutics" on BioPortfolio

We have published hundreds of Chelsea Therapeutics news stories on BioPortfolio along with dozens of Chelsea Therapeutics Clinical Trials and PubMed Articles about Chelsea Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chelsea Therapeutics Companies in our database. You can also find out about relevant Chelsea Therapeutics Drugs and Medications on this site too.

Quick Search

Relevant Topic

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...


Corporate Database Quicklinks



Searches Linking to this Company Record